Dr Terri Cooper is a member of the Investment Committee and the Nominations Committee. Terri is a recognised life sciences healthcare expert, with more than 35 years’ experience working globally across public and private sectors with complex industry, business, technology, DEI, brand-building and regulatory imperatives. This includes leading Deloitte’s global healthcare sector and building the firm’s Life Sciences R&D practice. Terri is the board chair for Verso Biosense, the vice board chair for the Classical Theatre of Harlem and sits on the advisory boards of the USTA Foundation and EnrichedHQ. She holds a PhD in pharmacology from the University of London.
Dr Terri Cooper
Latest news
-
LifeArc Pathfinder Award recipients uncover genetic cause of severe nerve condition in children
-
LifeArc and Genetic Alliance UK launch a new report calling for the acceleration of research and development (R&D) for rare diseases
-
Innovative home monitoring service aims to improve care for patients with dementia